On September 2, 2021 RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, reported that it will present at the following virtual conferences in September (Press release, RedHill Biopharma, SEP 2, 2021, View Source [SID1234587165]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference (September 13-15, 2021)
Presentation: Available from Monday, September 13, 2021, 7:00 a.m. EDT
Speaker: Guy Goldberg, Chief Business Officer

Cantor Global Healthcare Conference (September 27-30, 2021)
Fireside chat: will be broadcast live on Thursday, September 30, 2021, 8:40 a.m. EDT and available for replay
Moderator: Brandon Folkes, CFA, Director, Equity Research – Healthcare, Biopharma
Speaker: Guy Goldberg, Chief Business Officer

The webcasts will be available for 30 days on the Company’s website under the Investors page: www.redhillbio.com.